Download Files:
Rovadicitinib
SKU
HY-148798-Get quote
Category Reference compound
Tags Cancer, Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt, JAK
Products Details
Product Description
– Rovadicitinib is a Janus kinase (JAK) inhibitor with an IC50 value <20 nM. Rovadicitinib also exhibits anti-inflammatory activity[1][2].
Web ID
– HY-148798
Shipping
– Room temperature
Molecular Formula
– C17H19N7
References
– [1]WHO Drug Informat ion – World Health Organization (WHO).|[2]Zhu Li, et al. Preparation of pyrrolopyrimidines as Janus kinase inhibitors: Preparation of pyrrolopyrimidines as Janus kinase inhibitors: World Intellectual Property Organization, WO2016095805. 2016-06-23.|[3]WHO Drug Information-World Health Organization (WHO).
CAS Number
– 1948242-59-8
Molecular Weight
– 321.38
SMILES
– NC1=NN([C@@H](C2CCCC2)CC#N)C=C1C3=C4C(NC=C4)=NC=N3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– JAK
Pathway
– Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.